Loading...
Header Logo
Keywords
Last Name
Institution

Search Results (161)

Click the Why column to see why an item matched the search.

MatchTypeWhy
Usmani, SaadPerson Why?
Multiple myeloma.Academic Article Why?
Adenovirus vector-based purging of multiple myeloma cells.Academic Article Why?
Characterization of the molecular mechanism of the bone-anabolic activity of carfilzomib in multiple myeloma.Academic Article Why?
Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma.Academic Article Why?
Clinical potential of SLAMF7 antibodies - focus on elotuzumab in multiple myeloma.Academic Article Why?
Clinicopathological features of extramedullary recurrence/relapse of multiple myeloma.Academic Article Why?
Cutaneous manifestations of multiple myeloma and other plasma cell proliferative disorders.Academic Article Why?
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma.Academic Article Why?
Detection of Kaposi's sarcoma herpesvirus DNA sequences in multiple myeloma bone marrow stromal cells.Academic Article Why?
HSP90 inhibitors as therapy for multiple myeloma.Academic Article Why?
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.Academic Article Why?
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.Academic Article Why?
Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma.Academic Article Why?
Molecular chaperone gp96 is a novel therapeutic target of multiple myeloma.Academic Article Why?
Per Page    Page  of 11last Nextnext
Prev
Search Criteria
  • Multiple Myeloma
Filter by Type